|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bacteria Infection | |||||
| Respiratory Tract Infections | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Birth Weight | |||||
| Communicable Diseases | |||||
| Infection | |||||
| Ureaplasma Infections | |||||
| 3 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Body Weight | |||||
| Gram-Negative Bacterial Infections | |||||
| Mycoplasmatales Infections | |||||
| Respiratory Tract Diseases | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Azithromycin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Alabama at Birmingham | |||||